The software publisher based in Nice, which has developed a solution for reading mammograms by artificial intelligence, announces a series B funding round which will notably enable it to accelerate its commercial presence in the United States. New fundraising for Therapixel which, three years after raising €5M in Series A, announces a round of €15M … Read more
Classé dans : Les affaires, Science et technologie, SantéSujets : Femme, Contrats de license / de marketing HALIFAX, NS, le 12 mai 2022 /CNW/ – Densitas® Inc., un fournisseur mondial de technologies d’intelligence artificielle (IA) pour la mammographie numérique et le dépistage du cancer du sein, a annoncé l’expansion de son entente de partenariat avec Blackford, ce … Read more
Posted on Wednesday, May 11, 2022 Noxxon Pharma, a biotechnology company specializing in the development of improved cancer treatments targeting the tumor microenvironment (MET), has announced the appointment of two leading brain cancer experts to its Scientific Advisory Board (SAB). Professor Monika Hegi and Doctor Michael Lim join the current SAB and provide strategic and … Read more
A new way to use artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed by a team including medical scientists from the University of Leeds. Artificial intelligence (AI) can analyze large amounts of data, such as images or test results, and can identify patterns often undetectable by … Read more
A drug to treat metastatic kidney cancer, still incurable? This idea sprang up in 2008 “on the edge of the lab bench” from Dr Gilles Pagès, now director of research at the National Institute for Health and Medical Research (Inserm) first class and team leader within from the Cancer and Aging Institute (Ircan) in Nice. … Read more
Median has received the response from the FDA regarding its 513(g) filing for iBiopsy® LCS CADe/CADx medical device software. Median will file a 510(k) filing for FDA marketing clearance for its medical device software, scheduled for late 2023. On May 2, Median initiated a process of preliminary submissions (Q-submission), in order to obtain the opinion … Read more
⇧ [VIDÉO] You might also like this partner content (after ad) Pancreatic cancer remains one of the most difficult to treat. In fact, the diagnosis of pancreatic duct adenocarcinoma is delayed by the absence of symptoms and specific diagnostic biomarkers. Developed by Cedars-Sinai researchers, an artificial intelligence tool was trained on CT images taken months … Read more
How can artificial intelligence help medicine? It can be very useful for analysis. The image is pixels: quantitative data that lends itself very well to exploitation by algorithms. It takes a lot of images and therefore a lot of patients to train the algorithm; we also integrate clinical data such as age, sex or the … Read more
Lung cancer soon diagnosed thanks to a simple blood test? New research work on early detection has been undertaken by specialists from the Nice University Hospital. Presented by 20 minutes at the beginning of 2020 and stopped short by the start of the health crisis, they will finally be able to resume two years later. … Read more
Publié le 04/04/2022 à 17h50 La radiothérapie consiste à utiliser des rayonnements pour détruire les cellules cancéreuses et empêcher leur multiplication. Ce domaine a bénéficié des progrès en biologie, imagerie et intelligence artificielle. En France, en 2020, 2.3 millions de nouveaux cas de cancer ont été détectés et le nombre de cas continue d’augmenter en raison … Read more